Oxytocin: The Complex Science of the “Love Hormone”

Only a few molecules in neuroscience have a career path as strange as the hormone oxytocin. From products for couples to people on dating apps, this hormone has seen it all. Its reputation as the love hormone has obscured its true scientific value, and the truth about what it does is much more complex than advertisers would have you believe.

The marketing around this idea can be startlingly literal. A company called Vero Labs sells an unscented spray called “Liquid Trust,” pitched at salespeople, job seekers, and daters, with the promise that a single spritz will make anyone nearby see the wearer as more trustworthy. Online testimonials credit it with everything from a better bar tab in tips to a marriage proposal, despite there being no solid mechanism by which oxytocin absorbed through skin or briefly inhaled could produce that kind of effect on another person.

The wellness aisle tells a similar story: intranasal oxytocin sprays and supplements are sold as a “cuddle hormone” fix for everything from social anxiety to a flagging relationship, and wedding officiants and relationship coaches invoke it as the biological proof behind a first kiss or a long hug. None of these products is backed by the kind of evidence this article lays out below. But they capture just how far the “love hormone” label has travelled from the laboratory.

What Oxytocin Actually Is

Oxytocin is a small peptide hormone that the hypothalamus produces, and the pituitary gland releases into the bloodstream. Additionally, oxytocin is produced in the brain tissue as a regulator of social behaviour. Over the past century, scientists have studied oxytocin’s role in the human body after discovering that it promotes uterine contractions and milk ejection during labour and breastfeeding.

However, the association of oxytocin with love and trust long preceded its understanding. Researchers initially discovered oxytocin’s role in love and bonding through studies done on small mice-like animals called voles. Specifically, oxytocin and vasopressin hormones are likely to be responsible for the difference in the mating and parenting behaviours of the monogamous prairie voles (who are faithful to their partners) and their promiscuous meadow vole relatives (who have several partners) (Young & Wang, 2004).

The single most common human study was performed by Kosfeld et al., who discovered that participants who were dosed with oxytocin via nasal spray were more likely to give a larger share of money to their partner in a trust game than those who got the placebo. This effect was specific to interpersonal interaction, as those who played against the computer did not show increased oxytocin compared to the control group, suggesting that the hormone did not act to decrease general risk but rather social risk specifically (Kosfeld et al., 2005). The study gained significant media attention and became a popular example of oxytocin’s effects.

Why “Love Hormone” Is a Misleading Label

The trouble is that the label never survived contact with follow-up research. Within a few years, other laboratories were finding effects that complicated this rosy picture. Oxytocin proved to promote envy and gloating in a competitive situation (Shamay-Tsoory et al., 2009). Increased defensive aggression and “peacemaking” behaviour directed against foreigners in unrelated conflicts (De Dreu et al., 2010; 2011). Decreased trust beyond a group context, favouring adherence to one’s own group’s viewpoint (Stallen et al., 2012). Most recently, researchers found that oxytocin can increase people’s willingness to lie for their own or their group’s benefit in certain contexts (Shalvi & De Dreu, 2014).

Taken together, this body of research suggests a modified version of the bonding hypothesis. This has led to an idea called ‘social importance’ (Bartz et al, 2011; Bos et al, 2012): oxytocin makes people notice social signals more in general, facilitating both positive and negative social behaviours depending on the context. In other words, oxytocin is not a ‘love hormone’ or ‘attachment hormone’ that biases the brain toward pair bonding. But rather acts as an amplifier for any kind of social interaction, increasing its perceived valence, be it positive or negative. There is also a harder methodological problem behind the popular narrative.

Much of the early enthusiasm was based on small studies using intranasal oxytocin. Later statistical analyses cast doubt on how much weight should be given to these findings. Quintana (2020) showed that many oxytocin studies examining the hormone’s effect on trust were statistically underpowered to find the effect sizes reported, and broader reviews also indicate that results are mixed across different paradigms and laboratories (Walum et al., 2016). At the same time, it is important to recognise that none of this negates oxytocin’s role as a social hormone in effect. Much research has been aimed at understanding how and why oxytocin’s effects often fail to appear in practice, or examining subtleties and complexities in the relationship between the hormone and specific behaviours.

Parenting, Attachment, and Emotional Regulation 

Where the evidence is comparatively strongest is in parent-infant bonding. Oxytocin rises in both parents around childbirth and during caregiving interactions such as touch, gaze, and feeding, and higher parental oxytocin levels have been associated with more synchronous, responsive caregiving behaviour (Feldman, 2012). Feldman’s research in particular has tracked oxytocin alongside behavioural synchrony between parents and infants, suggesting the hormone supports precise, two-way communication that underlies early attachment, rather than the hormone alone causing attachment.

Its role in broader emotional regulation is also complex. It suppresses the activity of the amygdala, which is one of the brain regions associated with fear and aggression, which might account for its role in reducing social anxiety and threat in specific contexts (Kirsch et al., 2005). However, due to the strong influence of individual factors such as attachment styles and social context, oxytocin’s ability to provide general emotional stability is limited. For instance, oxytocin can produce effects on social bonding that differ from researchers’ predictions in people with insecure attachment styles. (Bartz et al., 2010).

Therapeutic Potential, and Its Limits

Due to its involvement in social cognition, oxytocin has been tested as a potential treatment for various social dysfunction-associated conditions, including autism spectrum disorder. The initial small-scale trials have shown some promise, and the hormone became widely popular among medical professionals (Anagnostou et al., 2012). However, subsequent large-scale randomised trials failed to demonstrate the effectiveness of oxytocin in reducing the severity of the disease. The treatment was found to be “not beneficial for children and adolescents with autism spectrum disorder,” according to Sikich et al. (2021). Therefore, the clinical utility of oxytocin for patients with autism spectrum disorder remains controversial since most of the clinical trials conducted to prove its efficacy have led to inconsistent results (Ooi et al., 2017; Sikich et al., 2021).

Researchers in this field suggest that future studies on oxytocin should address the sources of contradiction. Rather than looking for one, arguing that differences in the doses, the sample sizes, and the individual characteristics of oxytocin receptors could explain mixed results (Quintana et al., 2021). Oxytocin’s contribution to the treatment of anxiety, social, and stress-related psychiatric disorders is beyond question. But it is not a universal remedy for any of them.

The More Honest Picture

First, the effect of oxytocin appears to be conditional in most cases, meaning it rarely triggers predictable, consistent reactions. The same hormone that makes people more trusting inside their “in-group” makes them more suspicious of outsiders (Stallen et al., 2012; De Dreu et al., 2011), while the same hormone that fosters attachment to one’s own child can undermine social bonds in people with an avoidant or anxious attachment style (Bartz et al., 2010; Feldman, 2012).

Second, many of oxytocin’s early findings had “statistical power problems,” resulting in numerous contradictory studies that questioned the initial conclusions (Quintana, 2020; Walum et al., 2016). And third, despite oxytocin’s promise, particularly in the context of autism spectrum disorder (ASD), so far, it has failed to demonstrate broad therapeutic benefits, although the mechanisms shaping those relationships are undoubtedly complex and worthy of further investigation (Sikich et al., 2021; Quintana et al., 2021).

None of this diminishes oxytocin in any way; it only makes it more fascinating. A hormone that intensifies whatever social cue is already present in the room – friendliness or hostility, bonding or jealousy is actually far more interesting than a simple “love hormone.” This perspective is perhaps even more valuable than a magic pill, although it may not be as convenient for marketing purposes. In reality, the influence of these hormones is complex and closely related to an individual’s psychological state.

References +

• Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., Wang, A. T., Pepa, L., Tanel, N., Kushki, A., & Hollander, E. (2012). Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomised controlled trial. *Molecular Autism, 3, 16.
• Bartz, J. A., Zaki, J., Bolger, N., Hollander, E., Ludwig, N. N., Kolevzon, A., & Ochsner, K. N. (2010). Oxytocin selectively improves empathic accuracy. *Psychological Science, 21*(10), 1426, 1428.
• Bartz, J. A., Zaki, J., Bolger, N., & Ochsner, K. N. (2011). Social effects of oxytocin in humans: Context and person matter. *Trends in Cognitive Sciences, 15*(7), 301, 309.
• Bos, P. A., Panksepp, J., Blute, R. M., & van Honk, J. (2012). Acute effects of steroid hormones and neuropeptides on human social-emotional behaviour: A review of single administration studies. Frontiers in Neuroendocrinology, 33(1), 17, 35.
• De Dreu, C. K. W., Greer, L. L., Handgraaf, M. J. J., Shalvi, S., Van Kleef, G. A., Baas, M., Ten Velden, F. S., Van Dijk, E., & Feith, S. W. W. (2010). The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science, 328(5984), 1408, 1411.
• De Dreu, C. K. W., Greer, L. L., Van Kleef, G. A., Shalvi, S., & Handgraaf, M. J. J. (2011). Oxytocin promotes human ethnocentrism. Proceedings of the National Academy of Sciences, 108(4), 1262, 1266.
• Feldman, R. (2012). Oxytocin and social affiliation in humans. Hormones and Behaviour, 61(3), 380, 391.
• Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25(49), 11489, 11493.
• Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673, 676.
• Ooi, Y. P., Weng, S. J., Kossowsky, J., Gerger, H., & Sung, M. (2017). Oxytocin and autism spectrum disorders: A systematic review and meta-analysis of randomised controlled trials. Pharmacopsychiatry, 50(1), 5, 13.
• Quintana, D. S. (2020). Most oxytocin administration studies are statistically underpowered to reliably detect (or reject) a wide range of effect sizes. Comprehensive Psychoneuroendocrinology, 4, 100014.
• Quintana, D. S., Guastella, A. J., & Rokicki, J. (2021). Advances in the field of intranasal oxytocin research: Lessons learned and future directions for clinical research. Molecular Psychiatry, 26, 80, 91.
• Shalvi, S., & De Dreu, C. K. W. (2014). Oxytocin promotes group-serving dishonesty. Proceedings of the National Academy of Sciences, 111(15), 5503, 5507.
• Shamay-Tsoory, S. G., Fischer, M., Dvash, J., Harari, H., Perach-Bloom, N., & Levkovitz, Y. (2009). Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biological Psychiatry, 66(9), 864, 870.
• Sikich, L., Kolevzon, A., King, B. H., McDougle, C. J., Sanders, K. B., Kim, S. J., Spanos, M., Chandrasekhar, T., Trelles, M. P., Rockhill, C. M., Palumbo, M. L., Witters Cundiff, A., Montgomery, A., Siper, P., Minjarez, M., Nowinski, L. A., Marler, S., Shuffrey, L. C., Alderman, C., Veenstra-VanderWeele, J. (2021). Intranasal oxytocin in children and adolescents with autism spectrum disorder. New England Journal of Medicine, 385(16), 1462, 1473.
• Stallen, M., De Dreu, C. K. W., Shalvi, S., Smidts, A., & Sanfey, A. G. (2012). The herding hormone: Oxytocin stimulates in-group conformity. Psychological Science, 23(11), 1288, 1292.
• Walum, H., Waldman, I. D., & Young, L. J. (2016). Statistical and methodological considerations for the interpretation of intranasal oxytocin studies. Biological Psychiatry, 79(3), 251, 257.
• Young, L. J., & Wang, Z. (2004). The neurobiology of pair bonding. Nature Neuroscience, 7(10), 1048, 1054